Profit rose to $651.9 million, or 65 cents per share, in the second quarter, ended on February 28, from $523.5 million, or 51 cents per share, a year earlier. Analysts, on average, expected the Deerfield, Illinois-based chain to earn 61 cents per share, according to Reuters Estimates. Sales rose 14.6 percent to $13.93 billion, while sales at stores open at least a year increased 8.9 percent.

-----

Gross margin rose to 28.96 percent from 28.44 a year earlier. Derek Leckow, analyst at Barrington Research, said the quarter showed Walgreen's continued strength, saying that it was "remarkable" that a company the size of Walgreen would post a 25 percent earnings increase, which Walgreen has in the past three quarters.

-----

Walgreen shares rose almost 3 percent in morning trading on the New York Stock Exchange, before drifting lower amid a wider market decline. The stock is up more than 7 percent since March 14. "The changing prescription mix was a nice tailwind, but the strong performance was also the result of better store productivity," Mitchell Corwin, analyst at Morningstar, said in a research note.

-----

Rival CVS/Caremark Corp. ( CVS.N ) had 6,196 stores as of February 24. The stock was down 0.5 percent at midday Monday, less than the 0.65 percent decline of the Standard & Poor's 500 index   .SPX . The stock trades at about 20.5 times next year's expected earnings, while CVS trades at a multiple of about 15.8, according to Reuters data.

-----

CHICAGO  (Reuters) - Walgreen Co. ( WAG.N ), one of the largest U.S. drugstore chains, posted a better-than-expected 25 percent increase in quarterly profit on Monday, boosted by strong holiday sales and continued growth in prescription drugs.The company also said a greater percentage of prescription sales came from more profitable generic drugs, while the mix of general merchandise sales shifted to higher-margin items.
